Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model.

Alshaer W, Hillaireau H, Vergnaud J, Mura S, Deloménie C, Sauvage F, Ismail S, Fattal E.

J Control Release. 2018 Feb 10;271:98-106. doi: 10.1016/j.jconrel.2017.12.022. Epub 2017 Dec 23.

PMID:
29277682
2.

Anti-Inflammatory Effect of Anti-TNF-α SiRNA Cationic Phosphorus Dendrimer Nanocomplexes Administered Intranasally in a Murine Acute Lung Injury Model.

Bohr A, Tsapis N, Andreana I, Chamarat A, Foged C, Delomenie C, Noiray M, El Brahmi N, Majoral JP, Mignani S, Fattal E.

Biomacromolecules. 2017 Aug 14;18(8):2379-2388. doi: 10.1021/acs.biomac.7b00572. Epub 2017 Jul 5.

PMID:
28639789
3.

Dendritic cells' death induced by contact sensitizers is controlled by Nrf2 and depends on glutathione levels.

El Ali Z, Deloménie C, Botton J, Pallardy M, Kerdine-Römer S.

Toxicol Appl Pharmacol. 2017 May 1;322:41-50. doi: 10.1016/j.taap.2017.02.014. Epub 2017 Feb 20.

PMID:
28219650
4.

Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model.

Leite Nascimento T, Hillaireau H, Vergnaud J, Rivano M, Deloménie C, Courilleau D, Arpicco S, Suk JS, Hanes J, Fattal E.

Int J Pharm. 2016 Nov 30;514(1):103-111. doi: 10.1016/j.ijpharm.2016.06.125.

5.

Development and validation of a custom microarray for global transcriptome profiling of the fungus Aspergillus nidulans.

Deloménie C, Grentzmann G, Oestreicher N, Mesnage R, Vélot C.

Curr Genet. 2016 Nov;62(4):897-910. Epub 2016 Apr 1.

PMID:
27038308
6.

Biological outcome and mapping of total factor cascades in response to HIF induction during regenerative angiogenesis.

Khatib AM, Lahlil R, Hagedorn M, Delomenie C, Christophe O, Denis C, Siegfried G.

Oncotarget. 2016 Mar 15;7(11):12102-20. doi: 10.18632/oncotarget.7728.

7.

Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.

Bisserier M, Berthouze-Duquesnes M, Breckler M, Tortosa F, Fazal L, de Régibus A, Laurent AC, Varin A, Lucas A, Branchereau M, Marck P, Schickel JN, Deloménie C, Cazorla O, Soulas-Sprauel P, Crozatier B, Morel E, Heymes C, Lezoualc'h F.

Circulation. 2015 Jan 27;131(4):390-400; discussion 400. doi: 10.1161/CIRCULATIONAHA.114.010686. Epub 2014 Nov 4.

PMID:
25369805
8.

Disturbed intestinal nitrogen homeostasis in a mouse model of high-fat diet-induced obesity and glucose intolerance.

Do TT, Hindlet P, Waligora-Dupriet AJ, Kapel N, Neveux N, Mignon V, Deloménie C, Farinotti R, Fève B, Buyse M.

Am J Physiol Endocrinol Metab. 2014 Mar;306(6):E668-80. doi: 10.1152/ajpendo.00437.2013. Epub 2014 Jan 14.

9.

Mechanistic study of the proangiogenic effect of osteoprotegerin.

Benslimane-Ahmim Z, Poirier F, Delomenie C, Lokajczyk A, Grelac F, Galy-Fauroux I, Mohamedi A, Fischer AM, Heymann D, Lutomski D, Boisson-Vidal C.

Angiogenesis. 2013 Jul;16(3):575-93. doi: 10.1007/s10456-013-9337-x. Epub 2013 Feb 6.

PMID:
23386104
10.

Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells.

Gong C, Bauvy C, Tonelli G, Yue W, Deloménie C, Nicolas V, Zhu Y, Domergue V, Marin-Esteban V, Tharinger H, Delbos L, Gary-Gouy H, Morel AP, Ghavami S, Song E, Codogno P, Mehrpour M.

Oncogene. 2013 May 2;32(18):2261-72, 2272e.1-11. doi: 10.1038/onc.2012.252. Epub 2012 Jun 25.

11.

Ventral hippocampal molecular pathways and impaired neurogenesis associated with 5-HT₁A and 5-HT₁B receptors disruption in mice.

Xia L, Deloménie C, David I, Rainer Q, Marouard M, Delacroix H, David DJ, Gardier AM, Guilloux JP.

Neurosci Lett. 2012 Jul 11;521(1):20-5. doi: 10.1016/j.neulet.2012.05.046. Epub 2012 May 20.

PMID:
22622174
12.

Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells.

Mura S, Hillaireau H, Nicolas J, Kerdine-Römer S, Le Droumaguet B, Deloménie C, Nicolas V, Pallardy M, Tsapis N, Fattal E.

Biomacromolecules. 2011 Nov 14;12(11):4136-43. doi: 10.1021/bm201226x. Epub 2011 Oct 28.

PMID:
21981120
13.

Reduced intestinal absorption of dipeptides via PepT1 in mice with diet-induced obesity is associated with leptin receptor down-regulation.

Hindlet P, Bado A, Kamenicky P, Deloménie C, Bourasset F, Nazaret C, Farinotti R, Buyse M.

J Biol Chem. 2009 Mar 13;284(11):6801-8. doi: 10.1074/jbc.M805564200. Epub 2009 Jan 14.

14.

Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression.

Denève C, Deloménie C, Barc MC, Collignon A, Janoir C.

J Med Microbiol. 2008 Jun;57(Pt 6):732-8. doi: 10.1099/jmm.0.47676-0.

PMID:
18480330
15.

Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus.

Deltheil T, Guiard BP, Guilloux JP, Nicolas L, Deloménie C, Repérant C, Le Maitre E, Leroux-Nicollet I, Benmansour S, Coudoré F, David DJ, Gardier AM.

Pharmacol Biochem Behav. 2008 Aug;90(2):174-83. Epub 2007 Oct 3. Review.

PMID:
17980409
16.

Fatty acid incorporation in endothelial cells and effects on endothelial nitric oxide synthase.

Couloubaly S, Deloménie C, Rousseau D, Paul JL, Grynberg A, Pourci ML.

Eur J Clin Invest. 2007 Sep;37(9):692-9.

PMID:
17696958
17.

Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system.

Kim HR, Andrieux K, Delomenie C, Chacun H, Appel M, Desmaële D, Taran F, Georgin D, Couvreur P, Taverna M.

Electrophoresis. 2007 Jul;28(13):2252-61.

PMID:
17557357
18.

A new homolog of FocA transporters identified in cadmium-resistant Euglena gracilis.

Deloménie C, Foti E, Floch E, Diderot V, Porquet D, Dupuy C, Bonaly J.

Biochem Biophys Res Commun. 2007 Jun 29;358(2):455-61. Epub 2007 May 2.

PMID:
17499216
19.

5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice.

Cachard-Chastel M, Lezoualc'h F, Dewachter I, Deloménie C, Croes S, Devijver H, Langlois M, Van Leuven F, Sicsic S, Gardier AM.

Br J Pharmacol. 2007 Apr;150(7):883-92. Epub 2007 Feb 26.

20.

Increased expression of MDR1 mRNAs and P-glycoprotein in placentas from HIV-1 infected women.

Camus M, Deloménie C, Didier N, Faye A, Gil S, Dauge MC, Mabondzo A, Farinotti R.

Placenta. 2006 Jun-Jul;27(6-7):699-706. Epub 2005 Sep 12.

PMID:
16165208
21.

Peroxisome proliferator-activated receptor alpha physically interacts with CCAAT/enhancer binding protein (C/EBPbeta) to inhibit C/EBPbeta-responsive alpha1-acid glycoprotein gene expression.

Mouthiers A, Baillet A, Deloménie C, Porquet D, Mejdoubi-Charef N.

Mol Endocrinol. 2005 May;19(5):1135-46. Epub 2005 Jan 20.

PMID:
15661831
22.

Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles.

Garnier A, Fortin D, Deloménie C, Momken I, Veksler V, Ventura-Clapier R.

J Physiol. 2003 Sep 1;551(Pt 2):491-501. Epub 2003 Jun 24.

23.

Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation.

Lipskaia L, Pourci ML, Deloménie C, Combettes L, Goudounèche D, Paul JL, Capiod T, Lompré AM.

Circ Res. 2003 May 30;92(10):1115-22. Epub 2003 May 1.

PMID:
12730091
24.

Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma.

Gallou C, Longuemaux S, Deloménie C, Méjean A, Martin N, Martinet S, Palais G, Bouvier R, Droz D, Krishnamoorthy R, Junien C, Béroud C, Dupret JM.

Pharmacogenetics. 2001 Aug;11(6):521-35.

PMID:
11505222
25.
26.

Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid.

Deloménie C, Fouix S, Longuemaux S, Brahimi N, Bizet C, Picard B, Denamur E, Dupret JM.

J Bacteriol. 2001 Jun;183(11):3417-27.

27.

[Prevention of renal carcinoma: the nutri-genetic approach].

Junien C, Dupret JM, Gallou C, Longuemaux S, Richard S, Saquet C, Krishnamoorty R, Delomenie C, Droz D, Bouvier R, Chauveau D, Joly D, Grunfeld JP, Chretien Y, Mejean A, Beroud C.

J Soc Biol. 2000;194(1):29-38. Review. French.

PMID:
11107547
28.

Human glucocerebrosidase: heterologous expression of active site mutants in murine null cells.

Fabrega S, Durand P, Codogno P, Bauvy C, Delomenie C, Henrissat B, Martin BM, McKinney C, Ginns EI, Mornon JP, Lehn P.

Glycobiology. 2000 Nov;10(11):1217-24.

PMID:
11087714
29.

Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.

Longuemaux S, Deloménie C, Gallou C, Méjean A, Vincent-Viry M, Bouvier R, Droz D, Krishnamoorthy R, Galteau MM, Junien C, Béroud C, Dupret JM.

Cancer Res. 1999 Jun 15;59(12):2903-8.

30.

Glutathione S-transferase (GSTM1) null genotype and sulphonamide intolerance in acquired immunodeficiency syndrome.

Deloménie C, Mathelier-Fusade P, Longuemaux S, Rozenbaum W, Leynadier F, Krishnamoorthy R, Dupret JM.

Pharmacogenetics. 1997 Dec;7(6):519-20. No abstract available.

PMID:
9429238
31.
32.

Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations.

Deloménie C, Sica L, Grant DM, Krishnamoorthy R, Dupret JM.

Pharmacogenetics. 1996 Apr;6(2):177-85.

PMID:
9156695
33.

N-acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients.

Deloménie C, Grant DM, Mathelier-Fusade P, Jacomet C, Leynadier F, Jacqz-Aigrain E, Rozenbaum W, Krishnamoorthy R, Dupret JM.

Br J Clin Pharmacol. 1994 Dec;38(6):581-2. No abstract available.

35.

Comparison of in vivo acute lethal potency and in vitro cytotoxicity of 48 chemicals.

Shrivastava R, Delomenie C, Chevalier A, John G, Ekwall B, Walum E, Massingham R.

Cell Biol Toxicol. 1992 Apr-Jun;8(2):157-70.

PMID:
1422925

Supplemental Content

Loading ...
Support Center